Rajkot

Optimal environment to natural, personal and professional development leading to the making of responsible citizens. The day begins in the holy and spiritual environment with a prayer. Complete discipline, unfitness and the unity brought to be attained thought a dress code for staff members and students.

Alembic Limited, with an established presence in the Indian pharma  industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs1000 crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies.

This time people performed well. looks like approved than previous tests. Passing marks was 40 % and so many of the candidates reach there to pass. Let me remind you there was no negative marks system otherwise it can affect your result. But anyways overall it was nice performance.

That was real traffic of candidates on GPAT-TUTOR Platform for OCF 2011's test-2. The no. of candidates participating in OCF competition is increased for TEST-2. The test was much easier than test -1 and passing percentage was 50 % ... But Let me tell you very few of you cross that margin. But don’t worry as in GPAT if you would score atleast 35-40 %, you can qualify the pharma giant entrance.

Students from around 190 different colleges of India were registered for first test of OCF - 2011. And average result was poor for this test... Many of the participants failed to cross even 50 % marks. But no need to worry Test - 2 is waiting for you all. It will be on 21^st August, 2011

In an urge to provide quality pharma education online, PharmaTutor.org has decided to conduct an online competition focusing various pharma entrance exams such as GPAT, NIPER-JEE, CET, MAHE, Bits-exam, NMAT and others.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.We offer stimulating work environment & a career that spells growth.